Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.26 HKD | -1.09% | -0.14% | +3.86% |
25/04 | Kangji Medical Holdings Limited Proposes Special Dividend for the Year Ended December 31, 2023 | CI |
21/03 | Kangji Medical Holdings' Profit Rises 5% in 2023 | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- From a short-term investment perspective, the company presents a deteriorated fundamental situation
Strengths
- Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- The company's "enterprise value to sales" ratio is among the highest in the world.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- For the last four months, the sales outlook for the coming years has been revised downwards. No recovery of the group's activities is yet foreseen.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+3.86% | 1.14B | - | ||
-30.75% | 3.07B | B- | ||
-15.97% | 2.52B | C+ | ||
+18.11% | 2.47B | - | A- | |
+2.96% | 2B | B | ||
-9.47% | 1.91B | - | ||
-3.33% | 1.47B | B | ||
+2.24% | 1.33B | - | ||
+19.46% | 1.19B | C | ||
-1.70% | 1.03B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- 9997 Stock
- Ratings Kangji Medical Holdings Limited